Benzinga | Nov 10, 2020 07:35AM EST

Prelude Therapeutics Q3 EPS $(5.25) Down From $(3.93) YoY

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(5.25) per share. This is a 33.59 percent decrease over losses of $(3.93) per share from the same period last year.